| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.36 | 9e-13 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.33 | 6e-12 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |